Get started
Author

Marc Azémar

Observed names: Azémar, Marc, Marc Azemar, Marc Azèmar
OpenAlex ID: A5111590385
Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera
2000 · Snežana Temerinac, Steffen Klippel, et al. · Blood · 207
Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit thein vitro growth of human head and neck cancer cells and cause rapid tumor regressionin vivo
2000 · Marc Azemar, Mathias Schmidt, et al. · International Journal of Cancer · 105
PDF
Regression of Cutaneous Tumor Lesions in Patients Intratumorally Injected with a Recombinant Single-chain Antibody-toxin Targeted to ErbB2/HER2
2003 · Marc Azemar, Sirus Djahansouzi, et al. · Breast Cancer Research and Treatment · 95
Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases
2011 · Gerhard J. Molderings, Martin Raithel, et al. · Internal Medicine · 62
PDF
c-kit (CD117) Expression in Human Tumors and its Prognostic Value: An Immunohistochemical Analysis
2010 · Michael Medinger, Manuela Kleinschmidt, et al. · Pathology & Oncology Research · 37
Clinical Benefit in Patients with Advanced Solid Tumors Treated with Modified Citrus Pectin: A Prospective Pilot Study
2007 · Marc Azémar, Bernd Hildenbrand, et al. · Clinical medicine Oncology · 37
PDF
Tumour Biology: tumour-associated inflammation versus antitumor immunity.
2009 · Boris Müller-Hübenthal, Marc Azemar, et al. · PubMed · 28
Treatment of Anthracycline Extravasation with Dexrazoxane – Clinical Experience
2006 · Annette Frost, Daniela Gmehling, et al. · Oncology Research and Treatment · 22
IFN-y enhances T(H)1 polarisation of monocyte-derived dendritic cells matured with clinical-grade cytokines using serum-free conditions.
2008 · Bernd Hildenbrand, Dirk Lorenzen, et al. · PubMed · 12
Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature
2016 · Julia Quidde, Marc Azémar, et al. · Therapeutic Advances in Medical Oncology · 11
PDF
Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells
2014 · Matjaz Humar, Marc Azemar, et al. · Frontiers in Oncology · 4
PDF
DNA vaccination with a mutated p53 allele induces specific cytolytic T cells and protects against tumor cell growth and the formation of metastasis
2008 · Matjaz Humar, Martina Maurer, et al. · Journal of Cancer Research and Clinical Oncology · 4
Palliative Treatment: Anticancer, Antisymptom, or End-of-Life Care?
2011 · Jann Arends, Klaus Mross, et al. · Journal of Clinical Oncology · 3
Cytotoxic efficacy and influence on cellular phospholipid metabolism of 2-hydroxy- and 2-O-acetyl-octadecylphosphocholines.
2006 · Bernd Hildenbrand, Jörg T Kley, et al. · PubMed · 1
Direction of the Recognition Specificity of Cytotoxic T Cells Toward Tumor Cells by Transduced, Chimeric T-Cell Receptor Genes
2003 · Martina Maurer-Gebhard, Marc Azémar, et al. · Humana Press eBooks · 1
Radiotherapy for SMAD4-negative musculoskeletal lesions from pancreatic cancer
2014 · Constantinos Zamboglou, Peter Bronsert, et al. · Strahlentherapie und Onkologie
Measuring tumor cell apoptosis and necrosis in blood samples of cancer patients during therapy
2007 · Frank Neumann, K. Mross, et al. · Clinical Cancer Research
Proliferation and survival of mammary carcinoma cells are influenced by culture conditions used for ex vivo expansion of CD34+ blood progenitors
1998 · Spyridonidis, Alexandros, Bernhardt, Wiebke, et al. · FreiDok plus (Universitätsbibliothek Freiburg)
Complexe majeur d'histocompatibilite de l'homme : polymorphisme de restriction de l'adn des genes de classe i et de classe ii : (synthese des resultats parus dans la litterature jusqu'en juillet 1985)
1986 · Marc Azémar
Works count: 20
Citation count: 629
H-index: 10
I10-index: 10
Year
Topic
Type